Clinical utility of capillary polymerase chain reaction for diagnosis of cytomegalovirus pneumonia

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 9, 2001, Pages 702-705

  Honda, J ^a   Yonemitsu, J ^a   Kitajima, H ^a   Yosida, N ^a   Fumirori, T ^a   Oizumi, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAPILLARY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM; TISSUE SECTION; URINALYSIS; VIRUS DETECTION; VIRUS INCLUSION; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 0034792978     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110026908     Document Type: Article

References (26)

1. Effect of 9-(2-hydroxy-1[hydrooxymethyl] ethoxymethyl) guanine (DHPG) on cytomegalovirus pneumonitis after renal transplantation
2. Foscarnet for cytomegalovirus infection
3. Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia
4. Polymerase chain reaction for detection of Mycobacterium tuberculosis
5. Polymerase chain reaction monitoring reduced the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
6. Human cytomegalovirus DNA is not detectable with nested double polymerase chain reaction in healthy blood donors
7. Clinical utility of a quantitative polymerase chain reaction for diagnosis of cytomegalovirus disease in solid organ transplant patients
8. Comparative quantitation of human cytomegalovirus (CMV) in blood leukocytes and plasma of transplant and AIDS patients
9. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes
10. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: Correlation with disease
11. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients
12. Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes
13. CMV-antigenemia after allogeneic bone marrow transplantation: Correlation of CMV-antigen positive cell numbers with transplant-related mortality
14. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors
15. Detection of human cytomegalovirus
16. Structural analysis of the major immediate early gene of human cytomegalovirus
17. Rapid and sensitive diagnosis of cytomegalovirus and Pneumocystis carinii pneumonia in patients with haematological neoplasia by using capillary polymerase chain reaction
18. Rapid cycle DNA amplification: Time and temperature optimization
19. Differentiation of T cell lymphokine gene expression: The in vitro acquisition of T cell memory
20. Highly sensitive single-step PCR protocol for diagnosis and monitoring of human cytomegalovirus infection in renal transplant recipients
21. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation
22. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: Diagnostic value in renal transplant recipients
23. Human immunodeficiency virus type 1 and cytomegalovirus in saliva
24. Shedding of cytomegalovirus and herpesvirus 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls
25. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification
26. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients